Cartesian Therapeutics
RNAC
RNAC
93 hedge funds and large institutions have $69.1M invested in Cartesian Therapeutics in 2023 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 20 increasing their positions, 25 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.19% less ownership
Funds ownership: 1.21% → 1.02% (-0.19%)
20% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 25
Holders
93
Holding in Top 10
1
Calls
$87K
Puts
$8K
Top Buyers
| 1 | +$3.23M | |
| 2 | +$3.06M | |
| 3 | +$1.39M | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.14M |
| 5 |
HSBC Holdings
London,
United Kingdom
|
+$834K |
Top Sellers
| 1 | -$5.94M | |
| 2 | -$4.59M | |
| 3 | -$2.89M | |
| 4 |
ECM
Endurant Capital Management
San Mateo,
California
|
-$2.24M |
| 5 |
BI
BVF Inc
San Francisco,
California
|
-$1.57M |